FDA advisors recommend replacing original Covid vaccine with bivalent omicron shots for all doses
The Food and Drug Administration's independent advisory committee on Thursday unanimously recommended replacing Pfizer and Moderna's original Covid vaccine used in the U.S. for everyone's first two immunizations with the new bivalent omicron shots. Instead, the drugmakers' bivalent omicron shots that target the omicron BA.5 subvariant as well as the original strain would be used for the entire vaccination series. Currently, Pfizer's and Moderna's omicron shots are only authorized as a booster, while the first two doses are still their old shots based on the original Covid strain. The FDA has proposed moving to a system that resembles how the agency updates and rolls out flu shots every year. The agency would select a Covid vaccine formulation in June to target the variant that is expected to dominate in the fall and winter.
cnbc.comBritish regulator 1st to OK Moderna's updated COVID booster
British drug regulators have become the first in the world to authorize an updated version of Modernaโs coronavirus vaccine that includes protection against the omicron variant, which the government said would now be offered to people aged 50 and over in the fall.
British regulator 1st to OK Moderna's updated COVID booster
British drug regulators have become the first in the world to authorize an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the omicron variant. In a statement on Monday, the Medicines and Healthcare Regulatory Agency said it had given the green light to Moderna's combination โbivalentโ vaccine, which will be used as an adult booster shot. Each dose of the booster shot will target both the original COVID-19 virus that was first detected in 2020 and the omicron BA.1 variant that was first picked up in November.
news.yahoo.com